| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |